Flutamide
Back to searchMolecule Structure
Scientific Name
Flutamide
Description of the Drug
Flutamide is an antiandrogen used for locally confined stage B2-C and D-2 metastatic prostate carcinoma.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00499
http://www.drugbank.ca/drugs/DB00499
Brand Name(s)
Chimax, Drogenil, Eulexin, Flutamide
Company Owner(s)
Cipla Ltd, Waylis Therapeutics Llc, Schering Corp Sub Schering Plough Corp, Actavis Laboratories Fl Inc, Chartwell Rx Sciences Llc, Mylan Pharmaceuticals Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Androgen Receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL1871 |
Clinical Trial(s)
Unichem Links
Atlas | flutamide |
SureChEMBL | SCHEMBL3934 |
PharmGKB | PA449685 |
Human Metabolome Database | HMDB0014642 |
DrugBank | DB00499 |
PubChem: Thomson Pharma | 15222063 |
PubChem | 3397 |
Mcule | MCULE-7498839065 |
LINCS | LSM-2621 |
BindingDB | 50131270 |
EPA CompTox Dashboard | DTXSID7032004 |
DrugCentral | 1223 |
Brenda | 37969 |
ChemicalBook | CB2468110 |
Guide to Pharmacology | 6943 |
rxnorm | FLUTAMIDE |
PubChem: Drugs of the Future | 12013361 |
KEGG Ligand | C07653 |
ChEBI | 5132 |
ZINC | ZINC000003812944 |